Preclinical data to showcase the potential of regRNA-targeting to increase protein levels in a clinically meaningful way by upregulating gene expression Interim safety data including patient demographic data from all SAD cohorts of the first-in-human Phase 1 clinical trial of CMP-CPS-001 in healthy volunteers to be presented CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulat ...

PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today announced two presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting, which is being held from May 13-17, 2025, at the New Orleans Ernest N. Morial Convention Center in New Orleans, LA. The presentations will highligh ...

BURLINGTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (“the Company”), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today announced that it will deliver an oral presentation of compelling preclinical data from its Rejuva single-administration Smart GLP-1 pancreatic gene therapy platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting, taking place May 13- ...

SANTA MONICA, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on June 17, 2025, to stockholders of record at the close of business on June 3, 2025. About MacerichMacerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated ...

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference scheduled for May 5-6 2025 in Toronto, Ontario. Edesa management is scheduled to present on Monday, May 5 at 4:00pm ET. To meet with Edesa during the conference, please utilize the conference’s o ...

LOS ANGELES, April 28, 2025 (GLOBE NEWSWIRE) -- RBB Bancorp (NASDAQ:RBB) and its subsidiaries, Royal Business Bank (the “Bank”) and RBB Asset Management Company (“RAM”), collectively referred to herein as the “Company,” announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Highlights Net income totaled $2.3 million, or $0.13 diluted earnings per shareReturn on average assets of 0.24%, compared to 0.44% for the quarter ended December 31, 2024Net interest margin expanded to 2.88 ...

SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (“Trident” or the “Company,” NASDAQ: TDTH), a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 28, 2025 Eastern Time. The annual report can be accessed on the Company’s investor relations website ...

CHICAGO, April 28, 2025 (GLOBE NEWSWIRE) -- Portillo’s Inc. (“Portillo’s” or the “Company”) (NASDAQ: PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, today announced that it has entered into a cooperation agreement with Engaged Capital, LLC (“Engaged Capital”). As part of the cooperation agreement, Portillo’s and Engaged Capital will cooperate to identify a new director with recent and relevant restaurant operating experience to be appointed to the Portillo’s Board of ...

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we” or “our”), today announced its financial results for the fiscal year ended December 31, 2024. Operational and Financial Highlights for Fiscal Year 2024 Total net revenues in the 2024 fiscal year increased by 20.9% to US$5.9 million, from US$4.9 million in the 2023 fiscal year. Gross profit in the 2024 fiscal year was US$1.2 million, compared to a gross loss of US$16.7 million in the 2023 fiscal ...

文章核心观点 - 迪吉尼克斯公司宣布任命两位高级管理人员，这是其支持可持续和创新驱动经济的重要一步，有助于推进可持续监管科技解决方案及实现业务增长 [1][5] 公司动态 - 公司宣布任命丹·坎皮恩为全球首席商务官，洛伦佐·罗曼诺为并购首席战略顾问 [1][2][4] - 公司近期与罗素·贝德福德国际、福维斯·马扎尔和新加坡贝克·蒂利签署了战略联盟协议 [1] 新任命人员情况 丹·坎皮恩 - 拥有战略领导和业务发展方面的卓越职业生涯，将推动公司扩展环境、社会和治理（ESG）解决方案和可持续金融产品 [2] - 曾在多个行业担任高级领导职务，最近担任标准普尔全球市场销售全球主管，将负责公司全球商业战略，加速市场渗透 [3] 洛伦佐·罗曼诺 - 是一位经验丰富的银行高管，在私人银行、财富管理和战略增长咨询方面有出色业绩 [4] - 曾在多家银行担任重要职务，将帮助公司在可持续监管科技领域识别和执行增值交易 [4] 公司介绍 - 迪吉尼克斯是一家可持续监管科技企业，利用区块链、人工智能等技术，助力企业和政府简化ESG、气候和供应链数据收集与报告 [6] - 获奖的diginexESG平台支持17个全球框架，为客户提供从重要性评估到ESG评级支持服务等端到端支持 [7]